Medical Care
Global Gene Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 01, 25
- ID: 285570
- Pages: 137
- Figures: 141
- Views: 11
In 2024, the global market size of Gene Therapy was estimated to be worth US$ 11480 million and is forecast to reach approximately US$ 61870 million by 2031 with a CAGR of 27.6% during the forecast period 2025-2031.
Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson"s disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%.
North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent.
In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy.
The Gene Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Segment by Type
Viral Gene Therapy
Non-Viral Gene Therapy
Segment by Application
Neurological Diseases
Cancer
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Gene Therapy in global and regional level.
Chapter 3: Detailed analysis of Gene Therapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Therapy revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson"s disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%.
North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent.
In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy.
The Gene Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Segment by Type
Viral Gene Therapy
Non-Viral Gene Therapy
Segment by Application
Neurological Diseases
Cancer
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Gene Therapy in global and regional level.
Chapter 3: Detailed analysis of Gene Therapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Therapy revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Gene Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Gene Therapy Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Viral Gene Therapy
1.2.3 Non-Viral Gene Therapy
1.3 Market by Application
1.3.1 Global Gene Therapy Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gene Therapy Market Size Estimates and Forecasts
2.2 Gene Therapy Market Size by Region: 2024 Versus 2031
2.2.1 Global Gene Therapy Revenue by Region: 2020-2025
2.2.2 Global Gene Therapy Revenue Forecast by Region (2026-2031)
2.2.3 Global Gene Therapy Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Gene Therapy Revenue by Type (2020-2031)
3.1.2 Global Gene Therapy Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Gene Therapy Revenue by Application (2020-2031)
3.2.2 Global Gene Therapy Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Viral Gene Therapy of Gene Therapy Revenue Market Share by Application
3.3.2 Non-Viral Gene Therapy of Gene Therapy Revenue Market Share by Application
4 Global Gene Therapy by Company
4.1 Global Gene Therapy Revenue by Company (2020-2025)
4.2 Global Gene Therapy Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Gene Therapy Companies around the World: Ranking by Revenue
4.3.2 Global Gene Therapy Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Gene Therapy Companies Headquarters & Product Type
4.4.1 Global Gene Therapy Companies Headquarters
4.4.2 Date of International Companies Enter into Gene Therapy Market
4.4.3 Global Gene Therapy Companies Product & Service
4.4.4 Viral Gene Therapy Revenue Market Share of Gene Therapy by Company
4.4.5 Non-Viral Gene Therapy Revenue Market Share of Gene Therapy by Company
4.5 Global Gene Therapy Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Biogen
5.1.1 Biogen Corporation Information
5.1.2 Biogen Description, Business Overview
5.1.3 Biogen Gene Therapy Products Offered
5.1.4 Biogen Gene Therapy Revenue and Gross Margin (2020-2025)
5.1.5 Biogen Gene Therapy Revenue by Product in 2024
5.1.6 Biogen Gene Therapy Revenue by Application in 2024
5.1.7 Biogen Gene Therapy Revenue by Geographic Area in 2024
5.1.8 Biogen Recent Developments
5.2 Novartis
5.2.1 Novartis Corporation Information
5.2.2 Novartis Description, Business Overview
5.2.3 Novartis Gene Therapy Products Offered
5.2.4 Novartis Gene Therapy Revenue and Gross Margin (2020-2025)
5.2.5 Novartis Gene Therapy Revenue by Product in 2024
5.2.6 Novartis Gene Therapy Revenue by Application in 2024
5.2.7 Novartis Gene Therapy Revenue by Geographic Area in 2024
5.2.8 Novartis Recent Developments
5.3 Gilead Sciences
5.3.1 Gilead Sciences Corporation Information
5.3.2 Gilead Sciences Description, Business Overview
5.3.3 Gilead Sciences Gene Therapy Products Offered
5.3.4 Gilead Sciences Gene Therapy Revenue and Gross Margin (2020-2025)
5.3.5 Gilead Sciences Gene Therapy Revenue by Product in 2024
5.3.6 Gilead Sciences Gene Therapy Revenue by Application in 2024
5.3.7 Gilead Sciences Gene Therapy Revenue by Geographic Area in 2024
5.3.8 Gilead Sciences Recent Developments
5.4 Sarepta Therapeutics
5.4.1 Sarepta Therapeutics Corporation Information
5.4.2 Sarepta Therapeutics Description, Business Overview
5.4.3 Sarepta Therapeutics Gene Therapy Products Offered
5.4.4 Sarepta Therapeutics Gene Therapy Revenue and Gross Margin (2020-2025)
5.4.5 Sarepta Therapeutics Gene Therapy Revenue by Product in 2024
5.4.6 Sarepta Therapeutics Gene Therapy Revenue by Application in 2024
5.4.7 Sarepta Therapeutics Gene Therapy Revenue by Geographic Area in 2024
5.4.8 Sarepta Therapeutics Recent Developments
5.5 Alnylam Pharmaceuticals
5.5.1 Alnylam Pharmaceuticals Corporation Information
5.5.2 Alnylam Pharmaceuticals Description, Business Overview
5.5.3 Alnylam Pharmaceuticals Gene Therapy Products Offered
5.5.4 Alnylam Pharmaceuticals Gene Therapy Revenue and Gross Margin (2020-2025)
5.5.5 Alnylam Pharmaceuticals Gene Therapy Revenue by Product in 2024
5.5.6 Alnylam Pharmaceuticals Gene Therapy Revenue by Application in 2024
5.5.7 Alnylam Pharmaceuticals Gene Therapy Revenue by Geographic Area in 2024
5.5.8 Alnylam Pharmaceuticals Recent Developments
5.6 Amgen
5.6.1 Amgen Corporation Information
5.6.2 Amgen Description, Business Overview
5.6.3 Amgen Gene Therapy Products Offered
5.6.4 Amgen Gene Therapy Revenue and Gross Margin (2020-2025)
5.6.5 Amgen Gene Therapy Revenue by Product in 2024
5.6.6 Amgen Gene Therapy Revenue by Application in 2024
5.6.7 Amgen Gene Therapy Revenue by Geographic Area in 2024
5.6.8 Amgen Recent Developments
5.7 Spark Therapeutics
5.7.1 Spark Therapeutics Corporation Information
5.7.2 Spark Therapeutics Description, Business Overview
5.7.3 Spark Therapeutics Gene Therapy Products Offered
5.7.4 Spark Therapeutics Gene Therapy Revenue and Gross Margin (2020-2025)
5.7.5 Spark Therapeutics Gene Therapy Revenue by Product in 2024
5.7.6 Spark Therapeutics Gene Therapy Revenue by Application in 2024
5.7.7 Spark Therapeutics Gene Therapy Revenue by Geographic Area in 2024
5.7.8 Spark Therapeutics Recent Developments
5.8 Akcea Therapeutics
5.8.1 Akcea Therapeutics Corporation Information
5.8.2 Akcea Therapeutics Description, Business Overview
5.8.3 Akcea Therapeutics Gene Therapy Products Offered
5.8.4 Akcea Therapeutics Gene Therapy Revenue and Gross Margin (2020-2025)
5.8.5 Akcea Therapeutics Gene Therapy Revenue by Product in 2024
5.8.6 Akcea Therapeutics Gene Therapy Revenue by Application in 2024
5.8.7 Akcea Therapeutics Gene Therapy Revenue by Geographic Area in 2024
5.8.8 Akcea Therapeutics Recent Developments
5.9 bluebird bio
5.9.1 bluebird bio Corporation Information
5.9.2 bluebird bio Description, Business Overview
5.9.3 bluebird bio Gene Therapy Products Offered
5.9.4 bluebird bio Gene Therapy Revenue and Gross Margin (2020-2025)
5.9.5 bluebird bio Gene Therapy Revenue by Product in 2024
5.9.6 bluebird bio Gene Therapy Revenue by Application in 2024
5.9.7 bluebird bio Gene Therapy Revenue by Geographic Area in 2024
5.9.8 bluebird bio Recent Developments
5.10 Sunway Biotech
5.10.1 Sunway Biotech Corporation Information
5.10.2 Sunway Biotech Description, Business Overview
5.10.3 Sunway Biotech Gene Therapy Products Offered
5.10.4 Sunway Biotech Gene Therapy Revenue and Gross Margin (2020-2025)
5.10.5 Sunway Biotech Gene Therapy Revenue by Product in 2024
5.10.6 Sunway Biotech Gene Therapy Revenue by Application in 2024
5.10.7 Sunway Biotech Gene Therapy Revenue by Geographic Area in 2024
5.10.8 Sunway Biotech Recent Developments
5.11 SIBIONO
5.11.1 SIBIONO Corporation Information
5.11.2 SIBIONO Description, Business Overview
5.11.3 SIBIONO Gene Therapy Products Offered
5.11.4 SIBIONO Gene Therapy Revenue and Gross Margin (2020-2025)
5.11.5 SIBIONO Gene Therapy Revenue by Product in 2024
5.11.6 SIBIONO Gene Therapy Revenue by Application in 2024
5.11.7 SIBIONO Gene Therapy Revenue by Geographic Area in 2024
5.11.8 SIBIONO Recent Developments
5.12 AnGes
5.12.1 AnGes Corporation Information
5.12.2 AnGes Description, Business Overview
5.12.3 AnGes Gene Therapy Products Offered
5.12.4 AnGes Gene Therapy Revenue and Gross Margin (2020-2025)
5.12.5 AnGes Gene Therapy Revenue by Product in 2024
5.12.6 AnGes Gene Therapy Revenue by Application in 2024
5.12.7 AnGes Gene Therapy Revenue by Geographic Area in 2024
5.12.8 AnGes Recent Developments
5.13 Orchard Therapeutics
5.13.1 Orchard Therapeutics Corporation Information
5.13.2 Orchard Therapeutics Description, Business Overview
5.13.3 Orchard Therapeutics Gene Therapy Products Offered
5.13.4 Orchard Therapeutics Gene Therapy Revenue and Gross Margin (2020-2025)
5.13.5 Orchard Therapeutics Gene Therapy Revenue by Product in 2024
5.13.6 Orchard Therapeutics Gene Therapy Revenue by Application in 2024
5.13.7 Orchard Therapeutics Gene Therapy Revenue by Geographic Area in 2024
5.13.8 Orchard Therapeutics Recent Developments
5.14 Human Stem Cells Institute
5.14.1 Human Stem Cells Institute Corporation Information
5.14.2 Human Stem Cells Institute Description, Business Overview
5.14.3 Human Stem Cells Institute Gene Therapy Products Offered
5.14.4 Human Stem Cells Institute Gene Therapy Revenue and Gross Margin (2020-2025)
5.14.5 Human Stem Cells Institute Gene Therapy Revenue by Product in 2024
5.14.6 Human Stem Cells Institute Gene Therapy Revenue by Application in 2024
5.14.7 Human Stem Cells Institute Gene Therapy Revenue by Geographic Area in 2024
5.14.8 Human Stem Cells Institute Recent Developments
6 North America
6.1 North America Gene Therapy Market Size YoY Growth 2020-2031
6.2 North America Gene Therapy Market Facts & Figures by Country (2020-2031)
6.3 North America Gene Therapy Revenue by Type (2020-2025)
6.4 North America Gene Therapy Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Gene Therapy Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Gene Therapy Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Gene Therapy Revenue by Type (2020-2025)
7.4 Asia-Pacific Gene Therapy Revenue by Application (2020-2025)
8 Europe
8.1 Europe Gene Therapy Market Size YoY Growth 2020-2031
8.2 Europe Gene Therapy Market Facts & Figures by Country (2020-2031)
8.3 Europe Gene Therapy Revenue by Type (2020-2025)
8.4 Europe Gene Therapy Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Gene Therapy Market Size YoY Growth 2020-2031
9.2 Latin America Gene Therapy Market Facts & Figures by Country (2020-2031)
9.3 Latin America Gene Therapy Revenue by Type (2020-2025)
9.4 Latin America Gene Therapy Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Gene Therapy Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Gene Therapy Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Gene Therapy Revenue by Type (2020-2025)
10.4 Middle East and Africa Gene Therapy Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Gene Therapy Supply Chain Analysis
11.2 Gene Therapy Key Raw Materials and Upstream Suppliers
11.3 Gene Therapy Clients Analysis
11.4 Gene Therapy Sales Channel and Sales Model Analysis
11.4.1 Gene Therapy Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Gene Therapy Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Gene Therapy Distributors
12 Gene Therapy Market Dynamics
12.1 Gene Therapy Industry Trends
12.2 Gene Therapy Market Drivers
12.3 Gene Therapy Market Challenges
12.4 Gene Therapy Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Gene Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Gene Therapy Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Viral Gene Therapy
1.2.3 Non-Viral Gene Therapy
1.3 Market by Application
1.3.1 Global Gene Therapy Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gene Therapy Market Size Estimates and Forecasts
2.2 Gene Therapy Market Size by Region: 2024 Versus 2031
2.2.1 Global Gene Therapy Revenue by Region: 2020-2025
2.2.2 Global Gene Therapy Revenue Forecast by Region (2026-2031)
2.2.3 Global Gene Therapy Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Gene Therapy Revenue by Type (2020-2031)
3.1.2 Global Gene Therapy Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Gene Therapy Revenue by Application (2020-2031)
3.2.2 Global Gene Therapy Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Viral Gene Therapy of Gene Therapy Revenue Market Share by Application
3.3.2 Non-Viral Gene Therapy of Gene Therapy Revenue Market Share by Application
4 Global Gene Therapy by Company
4.1 Global Gene Therapy Revenue by Company (2020-2025)
4.2 Global Gene Therapy Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Gene Therapy Companies around the World: Ranking by Revenue
4.3.2 Global Gene Therapy Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Gene Therapy Companies Headquarters & Product Type
4.4.1 Global Gene Therapy Companies Headquarters
4.4.2 Date of International Companies Enter into Gene Therapy Market
4.4.3 Global Gene Therapy Companies Product & Service
4.4.4 Viral Gene Therapy Revenue Market Share of Gene Therapy by Company
4.4.5 Non-Viral Gene Therapy Revenue Market Share of Gene Therapy by Company
4.5 Global Gene Therapy Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Biogen
5.1.1 Biogen Corporation Information
5.1.2 Biogen Description, Business Overview
5.1.3 Biogen Gene Therapy Products Offered
5.1.4 Biogen Gene Therapy Revenue and Gross Margin (2020-2025)
5.1.5 Biogen Gene Therapy Revenue by Product in 2024
5.1.6 Biogen Gene Therapy Revenue by Application in 2024
5.1.7 Biogen Gene Therapy Revenue by Geographic Area in 2024
5.1.8 Biogen Recent Developments
5.2 Novartis
5.2.1 Novartis Corporation Information
5.2.2 Novartis Description, Business Overview
5.2.3 Novartis Gene Therapy Products Offered
5.2.4 Novartis Gene Therapy Revenue and Gross Margin (2020-2025)
5.2.5 Novartis Gene Therapy Revenue by Product in 2024
5.2.6 Novartis Gene Therapy Revenue by Application in 2024
5.2.7 Novartis Gene Therapy Revenue by Geographic Area in 2024
5.2.8 Novartis Recent Developments
5.3 Gilead Sciences
5.3.1 Gilead Sciences Corporation Information
5.3.2 Gilead Sciences Description, Business Overview
5.3.3 Gilead Sciences Gene Therapy Products Offered
5.3.4 Gilead Sciences Gene Therapy Revenue and Gross Margin (2020-2025)
5.3.5 Gilead Sciences Gene Therapy Revenue by Product in 2024
5.3.6 Gilead Sciences Gene Therapy Revenue by Application in 2024
5.3.7 Gilead Sciences Gene Therapy Revenue by Geographic Area in 2024
5.3.8 Gilead Sciences Recent Developments
5.4 Sarepta Therapeutics
5.4.1 Sarepta Therapeutics Corporation Information
5.4.2 Sarepta Therapeutics Description, Business Overview
5.4.3 Sarepta Therapeutics Gene Therapy Products Offered
5.4.4 Sarepta Therapeutics Gene Therapy Revenue and Gross Margin (2020-2025)
5.4.5 Sarepta Therapeutics Gene Therapy Revenue by Product in 2024
5.4.6 Sarepta Therapeutics Gene Therapy Revenue by Application in 2024
5.4.7 Sarepta Therapeutics Gene Therapy Revenue by Geographic Area in 2024
5.4.8 Sarepta Therapeutics Recent Developments
5.5 Alnylam Pharmaceuticals
5.5.1 Alnylam Pharmaceuticals Corporation Information
5.5.2 Alnylam Pharmaceuticals Description, Business Overview
5.5.3 Alnylam Pharmaceuticals Gene Therapy Products Offered
5.5.4 Alnylam Pharmaceuticals Gene Therapy Revenue and Gross Margin (2020-2025)
5.5.5 Alnylam Pharmaceuticals Gene Therapy Revenue by Product in 2024
5.5.6 Alnylam Pharmaceuticals Gene Therapy Revenue by Application in 2024
5.5.7 Alnylam Pharmaceuticals Gene Therapy Revenue by Geographic Area in 2024
5.5.8 Alnylam Pharmaceuticals Recent Developments
5.6 Amgen
5.6.1 Amgen Corporation Information
5.6.2 Amgen Description, Business Overview
5.6.3 Amgen Gene Therapy Products Offered
5.6.4 Amgen Gene Therapy Revenue and Gross Margin (2020-2025)
5.6.5 Amgen Gene Therapy Revenue by Product in 2024
5.6.6 Amgen Gene Therapy Revenue by Application in 2024
5.6.7 Amgen Gene Therapy Revenue by Geographic Area in 2024
5.6.8 Amgen Recent Developments
5.7 Spark Therapeutics
5.7.1 Spark Therapeutics Corporation Information
5.7.2 Spark Therapeutics Description, Business Overview
5.7.3 Spark Therapeutics Gene Therapy Products Offered
5.7.4 Spark Therapeutics Gene Therapy Revenue and Gross Margin (2020-2025)
5.7.5 Spark Therapeutics Gene Therapy Revenue by Product in 2024
5.7.6 Spark Therapeutics Gene Therapy Revenue by Application in 2024
5.7.7 Spark Therapeutics Gene Therapy Revenue by Geographic Area in 2024
5.7.8 Spark Therapeutics Recent Developments
5.8 Akcea Therapeutics
5.8.1 Akcea Therapeutics Corporation Information
5.8.2 Akcea Therapeutics Description, Business Overview
5.8.3 Akcea Therapeutics Gene Therapy Products Offered
5.8.4 Akcea Therapeutics Gene Therapy Revenue and Gross Margin (2020-2025)
5.8.5 Akcea Therapeutics Gene Therapy Revenue by Product in 2024
5.8.6 Akcea Therapeutics Gene Therapy Revenue by Application in 2024
5.8.7 Akcea Therapeutics Gene Therapy Revenue by Geographic Area in 2024
5.8.8 Akcea Therapeutics Recent Developments
5.9 bluebird bio
5.9.1 bluebird bio Corporation Information
5.9.2 bluebird bio Description, Business Overview
5.9.3 bluebird bio Gene Therapy Products Offered
5.9.4 bluebird bio Gene Therapy Revenue and Gross Margin (2020-2025)
5.9.5 bluebird bio Gene Therapy Revenue by Product in 2024
5.9.6 bluebird bio Gene Therapy Revenue by Application in 2024
5.9.7 bluebird bio Gene Therapy Revenue by Geographic Area in 2024
5.9.8 bluebird bio Recent Developments
5.10 Sunway Biotech
5.10.1 Sunway Biotech Corporation Information
5.10.2 Sunway Biotech Description, Business Overview
5.10.3 Sunway Biotech Gene Therapy Products Offered
5.10.4 Sunway Biotech Gene Therapy Revenue and Gross Margin (2020-2025)
5.10.5 Sunway Biotech Gene Therapy Revenue by Product in 2024
5.10.6 Sunway Biotech Gene Therapy Revenue by Application in 2024
5.10.7 Sunway Biotech Gene Therapy Revenue by Geographic Area in 2024
5.10.8 Sunway Biotech Recent Developments
5.11 SIBIONO
5.11.1 SIBIONO Corporation Information
5.11.2 SIBIONO Description, Business Overview
5.11.3 SIBIONO Gene Therapy Products Offered
5.11.4 SIBIONO Gene Therapy Revenue and Gross Margin (2020-2025)
5.11.5 SIBIONO Gene Therapy Revenue by Product in 2024
5.11.6 SIBIONO Gene Therapy Revenue by Application in 2024
5.11.7 SIBIONO Gene Therapy Revenue by Geographic Area in 2024
5.11.8 SIBIONO Recent Developments
5.12 AnGes
5.12.1 AnGes Corporation Information
5.12.2 AnGes Description, Business Overview
5.12.3 AnGes Gene Therapy Products Offered
5.12.4 AnGes Gene Therapy Revenue and Gross Margin (2020-2025)
5.12.5 AnGes Gene Therapy Revenue by Product in 2024
5.12.6 AnGes Gene Therapy Revenue by Application in 2024
5.12.7 AnGes Gene Therapy Revenue by Geographic Area in 2024
5.12.8 AnGes Recent Developments
5.13 Orchard Therapeutics
5.13.1 Orchard Therapeutics Corporation Information
5.13.2 Orchard Therapeutics Description, Business Overview
5.13.3 Orchard Therapeutics Gene Therapy Products Offered
5.13.4 Orchard Therapeutics Gene Therapy Revenue and Gross Margin (2020-2025)
5.13.5 Orchard Therapeutics Gene Therapy Revenue by Product in 2024
5.13.6 Orchard Therapeutics Gene Therapy Revenue by Application in 2024
5.13.7 Orchard Therapeutics Gene Therapy Revenue by Geographic Area in 2024
5.13.8 Orchard Therapeutics Recent Developments
5.14 Human Stem Cells Institute
5.14.1 Human Stem Cells Institute Corporation Information
5.14.2 Human Stem Cells Institute Description, Business Overview
5.14.3 Human Stem Cells Institute Gene Therapy Products Offered
5.14.4 Human Stem Cells Institute Gene Therapy Revenue and Gross Margin (2020-2025)
5.14.5 Human Stem Cells Institute Gene Therapy Revenue by Product in 2024
5.14.6 Human Stem Cells Institute Gene Therapy Revenue by Application in 2024
5.14.7 Human Stem Cells Institute Gene Therapy Revenue by Geographic Area in 2024
5.14.8 Human Stem Cells Institute Recent Developments
6 North America
6.1 North America Gene Therapy Market Size YoY Growth 2020-2031
6.2 North America Gene Therapy Market Facts & Figures by Country (2020-2031)
6.3 North America Gene Therapy Revenue by Type (2020-2025)
6.4 North America Gene Therapy Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Gene Therapy Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Gene Therapy Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Gene Therapy Revenue by Type (2020-2025)
7.4 Asia-Pacific Gene Therapy Revenue by Application (2020-2025)
8 Europe
8.1 Europe Gene Therapy Market Size YoY Growth 2020-2031
8.2 Europe Gene Therapy Market Facts & Figures by Country (2020-2031)
8.3 Europe Gene Therapy Revenue by Type (2020-2025)
8.4 Europe Gene Therapy Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Gene Therapy Market Size YoY Growth 2020-2031
9.2 Latin America Gene Therapy Market Facts & Figures by Country (2020-2031)
9.3 Latin America Gene Therapy Revenue by Type (2020-2025)
9.4 Latin America Gene Therapy Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Gene Therapy Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Gene Therapy Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Gene Therapy Revenue by Type (2020-2025)
10.4 Middle East and Africa Gene Therapy Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Gene Therapy Supply Chain Analysis
11.2 Gene Therapy Key Raw Materials and Upstream Suppliers
11.3 Gene Therapy Clients Analysis
11.4 Gene Therapy Sales Channel and Sales Model Analysis
11.4.1 Gene Therapy Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Gene Therapy Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Gene Therapy Distributors
12 Gene Therapy Market Dynamics
12.1 Gene Therapy Industry Trends
12.2 Gene Therapy Market Drivers
12.3 Gene Therapy Market Challenges
12.4 Gene Therapy Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Gene Therapy Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Gene Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Gene Therapy Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Gene Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Gene Therapy Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Gene Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Gene Therapy Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Gene Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Gene Therapy Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Gene Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 11. Gene Therapy Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Gene Therapy Players by Revenue (US$ Million) in 2024
Table 13. Global Gene Therapy Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy as of 2024)
Table 15. Global Gene Therapy Companies Headquarters
Table 16. Date of International Companies Enter into Gene Therapy Market
Table 17. Global Gene Therapy Companies Product & Service
Table 18. Global Gene Therapy Mergers & Acquisitions, Expansion Plans
Table 19. Biogen Corporation Information
Table 20. Biogen Description and Business Overview
Table 21. Biogen Gene Therapy Product
Table 22. Biogen Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Biogen Revenue Proportion of Gene Therapy by Product in 2024
Table 24. Biogen Revenue Proportion of Gene Therapy by Application in 2024
Table 25. Biogen Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 26. Biogen Recent Developments
Table 27. Novartis Corporation Information
Table 28. Novartis Description and Business Overview
Table 29. Novartis Gene Therapy Product
Table 30. Novartis Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Novartis Revenue Proportion of Gene Therapy by Product in 2024
Table 32. Novartis Revenue Proportion of Gene Therapy by Application in 2024
Table 33. Novartis Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 34. Novartis Recent Developments
Table 35. Gilead Sciences Corporation Information
Table 36. Gilead Sciences Description and Business Overview
Table 37. Gilead Sciences Gene Therapy Product
Table 38. Gilead Sciences Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Gilead Sciences Revenue Proportion of Gene Therapy by Product in 2024
Table 40. Gilead Sciences Revenue Proportion of Gene Therapy by Application in 2024
Table 41. Gilead Sciences Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 42. Gilead Sciences Recent Developments
Table 43. Sarepta Therapeutics Corporation Information
Table 44. Sarepta Therapeutics Description and Business Overview
Table 45. Sarepta Therapeutics Gene Therapy Product
Table 46. Sarepta Therapeutics Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Sarepta Therapeutics Revenue Proportion of Gene Therapy by Product in 2024
Table 48. Sarepta Therapeutics Revenue Proportion of Gene Therapy by Application in 2024
Table 49. Sarepta Therapeutics Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 50. Sarepta Therapeutics Recent Developments
Table 51. Alnylam Pharmaceuticals Corporation Information
Table 52. Alnylam Pharmaceuticals Description and Business Overview
Table 53. Alnylam Pharmaceuticals Gene Therapy Product
Table 54. Alnylam Pharmaceuticals Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Alnylam Pharmaceuticals Revenue Proportion of Gene Therapy by Product in 2024
Table 56. Alnylam Pharmaceuticals Revenue Proportion of Gene Therapy by Application in 2024
Table 57. Alnylam Pharmaceuticals Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 58. Alnylam Pharmaceuticals Recent Developments
Table 59. Amgen Corporation Information
Table 60. Amgen Description and Business Overview
Table 61. Amgen Gene Therapy Product
Table 62. Amgen Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Amgen Revenue Proportion of Gene Therapy by Product in 2024
Table 64. Amgen Revenue Proportion of Gene Therapy by Application in 2024
Table 65. Amgen Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 66. Amgen Recent Developments
Table 67. Spark Therapeutics Corporation Information
Table 68. Spark Therapeutics Description and Business Overview
Table 69. Spark Therapeutics Gene Therapy Product
Table 70. Spark Therapeutics Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Spark Therapeutics Revenue Proportion of Gene Therapy by Product in 2024
Table 72. Spark Therapeutics Revenue Proportion of Gene Therapy by Application in 2024
Table 73. Spark Therapeutics Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 74. Spark Therapeutics Recent Developments
Table 75. Akcea Therapeutics Corporation Information
Table 76. Akcea Therapeutics Description and Business Overview
Table 77. Akcea Therapeutics Gene Therapy Product
Table 78. Akcea Therapeutics Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Akcea Therapeutics Revenue Proportion of Gene Therapy by Product in 2024
Table 80. Akcea Therapeutics Revenue Proportion of Gene Therapy by Application in 2024
Table 81. Akcea Therapeutics Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 82. Akcea Therapeutics Recent Developments
Table 83. bluebird bio Corporation Information
Table 84. bluebird bio Description and Business Overview
Table 85. bluebird bio Gene Therapy Product
Table 86. bluebird bio Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. bluebird bio Revenue Proportion of Gene Therapy by Product in 2024
Table 88. bluebird bio Revenue Proportion of Gene Therapy by Application in 2024
Table 89. bluebird bio Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 90. bluebird bio Recent Developments
Table 91. Sunway Biotech Corporation Information
Table 92. Sunway Biotech Description and Business Overview
Table 93. Sunway Biotech Gene Therapy Product
Table 94. Sunway Biotech Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Sunway Biotech Revenue Proportion of Gene Therapy by Product in 2024
Table 96. Sunway Biotech Revenue Proportion of Gene Therapy by Application in 2024
Table 97. Sunway Biotech Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 98. Sunway Biotech Recent Developments
Table 99. SIBIONO Corporation Information
Table 100. SIBIONO Description and Business Overview
Table 101. SIBIONO Gene Therapy Product
Table 102. SIBIONO Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. SIBIONO Revenue Proportion of Gene Therapy by Product in 2024
Table 104. SIBIONO Revenue Proportion of Gene Therapy by Application in 2024
Table 105. SIBIONO Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 106. SIBIONO Recent Developments
Table 107. AnGes Corporation Information
Table 108. AnGes Description and Business Overview
Table 109. AnGes Gene Therapy Product
Table 110. AnGes Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. AnGes Revenue Proportion of Gene Therapy by Product in 2024
Table 112. AnGes Revenue Proportion of Gene Therapy by Application in 2024
Table 113. AnGes Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 114. AnGes Recent Developments
Table 115. Orchard Therapeutics Corporation Information
Table 116. Orchard Therapeutics Description and Business Overview
Table 117. Orchard Therapeutics Gene Therapy Product
Table 118. Orchard Therapeutics Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Orchard Therapeutics Revenue Proportion of Gene Therapy by Product in 2024
Table 120. Orchard Therapeutics Revenue Proportion of Gene Therapy by Application in 2024
Table 121. Orchard Therapeutics Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 122. Orchard Therapeutics Recent Developments
Table 123. Human Stem Cells Institute Corporation Information
Table 124. Human Stem Cells Institute Description and Business Overview
Table 125. Human Stem Cells Institute Gene Therapy Product
Table 126. Human Stem Cells Institute Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Human Stem Cells Institute Revenue Proportion of Gene Therapy by Product in 2024
Table 128. Human Stem Cells Institute Revenue Proportion of Gene Therapy by Application in 2024
Table 129. Human Stem Cells Institute Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 130. Human Stem Cells Institute Recent Developments
Table 131. North America Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 132. North America Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 133. North America Gene Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 134. North America Gene Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 135. Asia-Pacific Gene Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 136. Asia-Pacific Gene Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 137. Asia-Pacific Gene Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 138. Asia-Pacific Gene Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 139. Europe Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 140. Europe Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 141. Europe Gene Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 142. Europe Gene Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 143. Latin America Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 144. Latin America Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 145. Latin America Gene Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 146. Latin America Gene Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 147. Middle East and Africa Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 148. Middle East and Africa Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 149. Middle East and Africa Gene Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 150. Middle East and Africa Gene Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 151. Gene Therapy Key Raw Materials, Industry Status and Trend
Table 152. Gene Therapy Key Raw Materials and Upstream Suppliers
Table 153. Gene Therapy Clients Status and Trend
Table 154. Gene Therapy Typical Clients
Table 155. Gene Therapy Distributors
Table 156. Gene Therapy Market Trends
Table 157. Gene Therapy Market Drivers
Table 158. Gene Therapy Market Challenges
Table 159. Gene Therapy Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Gene Therapy Product Picture
Figure 2. Global Gene Therapy Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Gene Therapy Revenue Market Share by Type in 2024 & 2031
Figure 4. Viral Gene Therapy Product Picture
Figure 5. Non-Viral Gene Therapy Product Picture
Figure 6. Global Gene Therapy Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Gene Therapy Revenue Market Share by Application in 2024 & 2031
Figure 8. Neurological Diseases
Figure 9. Cancer
Figure 10. Other
Figure 11. Gene Therapy Report Years Considered
Figure 12. Global Gene Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Gene Therapy Market Size (2020-2031) & (US$ Million)
Figure 14. Global Gene Therapy Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Gene Therapy Revenue Market Share by Region (2020-2031)
Figure 16. Global Gene Therapy Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Gene Therapy Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Viral Gene Therapy of Gene Therapy Revenue Market Share by Application, 2024 VS 2031
Figure 19. Non-Viral Gene Therapy of Gene Therapy Revenue Market Share by Application, 2024 VS 2031
Figure 20. Gene Therapy Revenue Share by Company (2024)
Figure 21. Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Viral Gene Therapy Revenue Proportion by Company in 2024
Figure 23. Non-Viral Gene Therapy Revenue Proportion by Company in 2024
Figure 24. North America Gene Therapy Revenue 2020-2031 (US$ Million)
Figure 25. North America Gene Therapy Revenue Market Share by Type (2020-2025)
Figure 26. North America Gene Therapy Revenue Market Share by Application (2020-2025)
Figure 27. Asia-Pacific Gene Therapy Revenue 2020-2031 (US$ Million)
Figure 28. Asia-Pacific Gene Therapy Revenue Market Share by Region (2020-2031)
Figure 29. Asia-Pacific Gene Therapy Revenue Market Share by Type (2020-2025)
Figure 30. Asia-Pacific Gene Therapy Revenue Market Share by Application (2020-2025)
Figure 31. Europe Gene Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 32. Europe Gene Therapy Revenue Market Share by Country (2020-2031)
Figure 33. Europe Gene Therapy Revenue Market Share by Type (2020-2025)
Figure 34. Europe Gene Therapy Revenue Market Share by Application (2020-2025)
Figure 35. Latin America Gene Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 36. Latin America Gene Therapy Revenue Market Share by Country (2020-2031)
Figure 37. Latin America Gene Therapy Revenue Market Share by Type (2020-2025)
Figure 38. Latin America Gene Therapy Revenue Market Share by Application (2020-2025)
Figure 39. Middle East and Africa Gene Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Middle East and Africa Gene Therapy Revenue Market Share by Country (2020-2031)
Figure 41. Middle East and Africa Gene Therapy Revenue Market Share by Type (2020-2025)
Figure 42. Middle East and Africa Gene Therapy Revenue Market Share by Application (2020-2025)
Figure 43. Gene Therapy Supply Chain (Upstream and Downstream Market)
Figure 44. Global Production Market Share of Gene Therapy Raw Materials by Region in 2024
Figure 45. Gene Therapy Distribution Channels
Figure 46. Global Gene Therapy Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 47. Global Gene Therapy Percentage 2020-2031: Online Sales VS Offline Sales
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Table 1. Global Gene Therapy Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Gene Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Gene Therapy Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Gene Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Gene Therapy Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Gene Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Gene Therapy Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Gene Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Gene Therapy Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Gene Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 11. Gene Therapy Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Gene Therapy Players by Revenue (US$ Million) in 2024
Table 13. Global Gene Therapy Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy as of 2024)
Table 15. Global Gene Therapy Companies Headquarters
Table 16. Date of International Companies Enter into Gene Therapy Market
Table 17. Global Gene Therapy Companies Product & Service
Table 18. Global Gene Therapy Mergers & Acquisitions, Expansion Plans
Table 19. Biogen Corporation Information
Table 20. Biogen Description and Business Overview
Table 21. Biogen Gene Therapy Product
Table 22. Biogen Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Biogen Revenue Proportion of Gene Therapy by Product in 2024
Table 24. Biogen Revenue Proportion of Gene Therapy by Application in 2024
Table 25. Biogen Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 26. Biogen Recent Developments
Table 27. Novartis Corporation Information
Table 28. Novartis Description and Business Overview
Table 29. Novartis Gene Therapy Product
Table 30. Novartis Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Novartis Revenue Proportion of Gene Therapy by Product in 2024
Table 32. Novartis Revenue Proportion of Gene Therapy by Application in 2024
Table 33. Novartis Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 34. Novartis Recent Developments
Table 35. Gilead Sciences Corporation Information
Table 36. Gilead Sciences Description and Business Overview
Table 37. Gilead Sciences Gene Therapy Product
Table 38. Gilead Sciences Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Gilead Sciences Revenue Proportion of Gene Therapy by Product in 2024
Table 40. Gilead Sciences Revenue Proportion of Gene Therapy by Application in 2024
Table 41. Gilead Sciences Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 42. Gilead Sciences Recent Developments
Table 43. Sarepta Therapeutics Corporation Information
Table 44. Sarepta Therapeutics Description and Business Overview
Table 45. Sarepta Therapeutics Gene Therapy Product
Table 46. Sarepta Therapeutics Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Sarepta Therapeutics Revenue Proportion of Gene Therapy by Product in 2024
Table 48. Sarepta Therapeutics Revenue Proportion of Gene Therapy by Application in 2024
Table 49. Sarepta Therapeutics Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 50. Sarepta Therapeutics Recent Developments
Table 51. Alnylam Pharmaceuticals Corporation Information
Table 52. Alnylam Pharmaceuticals Description and Business Overview
Table 53. Alnylam Pharmaceuticals Gene Therapy Product
Table 54. Alnylam Pharmaceuticals Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Alnylam Pharmaceuticals Revenue Proportion of Gene Therapy by Product in 2024
Table 56. Alnylam Pharmaceuticals Revenue Proportion of Gene Therapy by Application in 2024
Table 57. Alnylam Pharmaceuticals Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 58. Alnylam Pharmaceuticals Recent Developments
Table 59. Amgen Corporation Information
Table 60. Amgen Description and Business Overview
Table 61. Amgen Gene Therapy Product
Table 62. Amgen Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Amgen Revenue Proportion of Gene Therapy by Product in 2024
Table 64. Amgen Revenue Proportion of Gene Therapy by Application in 2024
Table 65. Amgen Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 66. Amgen Recent Developments
Table 67. Spark Therapeutics Corporation Information
Table 68. Spark Therapeutics Description and Business Overview
Table 69. Spark Therapeutics Gene Therapy Product
Table 70. Spark Therapeutics Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Spark Therapeutics Revenue Proportion of Gene Therapy by Product in 2024
Table 72. Spark Therapeutics Revenue Proportion of Gene Therapy by Application in 2024
Table 73. Spark Therapeutics Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 74. Spark Therapeutics Recent Developments
Table 75. Akcea Therapeutics Corporation Information
Table 76. Akcea Therapeutics Description and Business Overview
Table 77. Akcea Therapeutics Gene Therapy Product
Table 78. Akcea Therapeutics Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Akcea Therapeutics Revenue Proportion of Gene Therapy by Product in 2024
Table 80. Akcea Therapeutics Revenue Proportion of Gene Therapy by Application in 2024
Table 81. Akcea Therapeutics Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 82. Akcea Therapeutics Recent Developments
Table 83. bluebird bio Corporation Information
Table 84. bluebird bio Description and Business Overview
Table 85. bluebird bio Gene Therapy Product
Table 86. bluebird bio Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. bluebird bio Revenue Proportion of Gene Therapy by Product in 2024
Table 88. bluebird bio Revenue Proportion of Gene Therapy by Application in 2024
Table 89. bluebird bio Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 90. bluebird bio Recent Developments
Table 91. Sunway Biotech Corporation Information
Table 92. Sunway Biotech Description and Business Overview
Table 93. Sunway Biotech Gene Therapy Product
Table 94. Sunway Biotech Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Sunway Biotech Revenue Proportion of Gene Therapy by Product in 2024
Table 96. Sunway Biotech Revenue Proportion of Gene Therapy by Application in 2024
Table 97. Sunway Biotech Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 98. Sunway Biotech Recent Developments
Table 99. SIBIONO Corporation Information
Table 100. SIBIONO Description and Business Overview
Table 101. SIBIONO Gene Therapy Product
Table 102. SIBIONO Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. SIBIONO Revenue Proportion of Gene Therapy by Product in 2024
Table 104. SIBIONO Revenue Proportion of Gene Therapy by Application in 2024
Table 105. SIBIONO Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 106. SIBIONO Recent Developments
Table 107. AnGes Corporation Information
Table 108. AnGes Description and Business Overview
Table 109. AnGes Gene Therapy Product
Table 110. AnGes Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. AnGes Revenue Proportion of Gene Therapy by Product in 2024
Table 112. AnGes Revenue Proportion of Gene Therapy by Application in 2024
Table 113. AnGes Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 114. AnGes Recent Developments
Table 115. Orchard Therapeutics Corporation Information
Table 116. Orchard Therapeutics Description and Business Overview
Table 117. Orchard Therapeutics Gene Therapy Product
Table 118. Orchard Therapeutics Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Orchard Therapeutics Revenue Proportion of Gene Therapy by Product in 2024
Table 120. Orchard Therapeutics Revenue Proportion of Gene Therapy by Application in 2024
Table 121. Orchard Therapeutics Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 122. Orchard Therapeutics Recent Developments
Table 123. Human Stem Cells Institute Corporation Information
Table 124. Human Stem Cells Institute Description and Business Overview
Table 125. Human Stem Cells Institute Gene Therapy Product
Table 126. Human Stem Cells Institute Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Human Stem Cells Institute Revenue Proportion of Gene Therapy by Product in 2024
Table 128. Human Stem Cells Institute Revenue Proportion of Gene Therapy by Application in 2024
Table 129. Human Stem Cells Institute Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 130. Human Stem Cells Institute Recent Developments
Table 131. North America Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 132. North America Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 133. North America Gene Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 134. North America Gene Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 135. Asia-Pacific Gene Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 136. Asia-Pacific Gene Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 137. Asia-Pacific Gene Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 138. Asia-Pacific Gene Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 139. Europe Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 140. Europe Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 141. Europe Gene Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 142. Europe Gene Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 143. Latin America Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 144. Latin America Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 145. Latin America Gene Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 146. Latin America Gene Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 147. Middle East and Africa Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 148. Middle East and Africa Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 149. Middle East and Africa Gene Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 150. Middle East and Africa Gene Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 151. Gene Therapy Key Raw Materials, Industry Status and Trend
Table 152. Gene Therapy Key Raw Materials and Upstream Suppliers
Table 153. Gene Therapy Clients Status and Trend
Table 154. Gene Therapy Typical Clients
Table 155. Gene Therapy Distributors
Table 156. Gene Therapy Market Trends
Table 157. Gene Therapy Market Drivers
Table 158. Gene Therapy Market Challenges
Table 159. Gene Therapy Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Gene Therapy Product Picture
Figure 2. Global Gene Therapy Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Gene Therapy Revenue Market Share by Type in 2024 & 2031
Figure 4. Viral Gene Therapy Product Picture
Figure 5. Non-Viral Gene Therapy Product Picture
Figure 6. Global Gene Therapy Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Gene Therapy Revenue Market Share by Application in 2024 & 2031
Figure 8. Neurological Diseases
Figure 9. Cancer
Figure 10. Other
Figure 11. Gene Therapy Report Years Considered
Figure 12. Global Gene Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Gene Therapy Market Size (2020-2031) & (US$ Million)
Figure 14. Global Gene Therapy Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Gene Therapy Revenue Market Share by Region (2020-2031)
Figure 16. Global Gene Therapy Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Gene Therapy Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Viral Gene Therapy of Gene Therapy Revenue Market Share by Application, 2024 VS 2031
Figure 19. Non-Viral Gene Therapy of Gene Therapy Revenue Market Share by Application, 2024 VS 2031
Figure 20. Gene Therapy Revenue Share by Company (2024)
Figure 21. Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Viral Gene Therapy Revenue Proportion by Company in 2024
Figure 23. Non-Viral Gene Therapy Revenue Proportion by Company in 2024
Figure 24. North America Gene Therapy Revenue 2020-2031 (US$ Million)
Figure 25. North America Gene Therapy Revenue Market Share by Type (2020-2025)
Figure 26. North America Gene Therapy Revenue Market Share by Application (2020-2025)
Figure 27. Asia-Pacific Gene Therapy Revenue 2020-2031 (US$ Million)
Figure 28. Asia-Pacific Gene Therapy Revenue Market Share by Region (2020-2031)
Figure 29. Asia-Pacific Gene Therapy Revenue Market Share by Type (2020-2025)
Figure 30. Asia-Pacific Gene Therapy Revenue Market Share by Application (2020-2025)
Figure 31. Europe Gene Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 32. Europe Gene Therapy Revenue Market Share by Country (2020-2031)
Figure 33. Europe Gene Therapy Revenue Market Share by Type (2020-2025)
Figure 34. Europe Gene Therapy Revenue Market Share by Application (2020-2025)
Figure 35. Latin America Gene Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 36. Latin America Gene Therapy Revenue Market Share by Country (2020-2031)
Figure 37. Latin America Gene Therapy Revenue Market Share by Type (2020-2025)
Figure 38. Latin America Gene Therapy Revenue Market Share by Application (2020-2025)
Figure 39. Middle East and Africa Gene Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Middle East and Africa Gene Therapy Revenue Market Share by Country (2020-2031)
Figure 41. Middle East and Africa Gene Therapy Revenue Market Share by Type (2020-2025)
Figure 42. Middle East and Africa Gene Therapy Revenue Market Share by Application (2020-2025)
Figure 43. Gene Therapy Supply Chain (Upstream and Downstream Market)
Figure 44. Global Production Market Share of Gene Therapy Raw Materials by Region in 2024
Figure 45. Gene Therapy Distribution Channels
Figure 46. Global Gene Therapy Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 47. Global Gene Therapy Percentage 2020-2031: Online Sales VS Offline Sales
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232